
Loading, please wait...

Loading, please wait...

Recent research explores the relationship between mTORC1 and endurance training, particularly how overactive signaling affects muscle adaptations. Mechanistic target of rapamycin complex I (mTORC1) acts as a master regulator of cell growth. While its activity typically increases with age, this hyperactivation often correlates with sarcopenia. Consequently, doctors are investigating whether this prevents the functional benefits of exercise. Therefore, understanding these pathways is essential for managing age-related muscle loss.
In a study using a DEPDC5 muscle-specific knockout mouse model, researchers examined the effects of an eight-week training program. The mice exhibited a notable increase in tibialis anterior muscle mass and mitochondrial activity. However, these physiological changes did not lead to improved physical function. Instead, the hyperactive mTORC1 appeared to blunt the expected functional gains. Specifically, the study highlighted a disconnect between muscle size and actual performance.
Moreover, the metabolic profile of the knockout mice showed significant alterations. Scientists observed a reduction in triglycerides and phosphatidylcholines within the muscle tissue. These changes suggest that the muscles increased their reliance on lipid fuels. Furthermore, the findings indicate that alterations in lipid membrane composition occurred alongside the increase in mitochondrial respiration. Therefore, while metabolic activity rose, the coordination required for functional improvement remained elusive.
Additionally, a trend toward reduced phosphorylation of ribosomal protein S6 was noted. This downstream target of mTORC1 is crucial for protein synthesis. Nevertheless, its potential suppression could explain why the increased muscle mass failed to enhance performance. In addition, these results suggest that excessive signaling disrupts the balance of adaptation. Ultimately, these findings could guide future strategies for maintaining muscle health in seniors.
Hyperactive mTORC1 can increase muscle mass and mitochondrial respiration, but it often prevents the expected improvements in physical performance and endurance.
DEPDC5 acts as an inhibitor of mTORC1; its absence leads to constitutive mTORC1 activation, which can paradoxically impair the quality of muscle adaptations to training.
The reduction in triglycerides and phosphatidylcholines suggests an increased utilization of lipid fuels and changes in membrane structure due to high mitochondrial activity.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. The application of this information in clinical settings should be done at the discretion of the healthcare provider. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study finds that hyperactive mTORC1 in muscle can increase mass and mitochondrial activity but may attenuate functional adaptations to endurance training....
4 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today